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TECHNICAL NOTES
A role for calcium in radiocontrast-induced reductions
in renal hemodynamics
GEORGE L. BAKRIS and JOHN C. BURNETT, JR.
Departments of Medicine and Physiology and Biophysics, Mayo Medical School, Rochester, Minnesota, USA
Intrarenal administration of radiocontrast medium yields a
prolonged vasoconstrictive response and reduction in glomer-
ular filtration rate (GFR) [1—31. This vasoconstrictor response is
unique to the kidney and follows an initial vasodilation charac-
teristic of the vascular response in other vascular beds during
radiocontrast medium administration [4—6]. The mechanism
which mediates the reduction in renal blood flow (RBF) and
glomerular filtration response to radiocontrast medium remains
obscure. Efforts to effectively abolish this vasoconstrictor
response with aipha-adrenoreceptor antagonists [2], angioten-
sin II blockers and angiotensin-converting enzyme inhibitors [7]
have proven unsuccessful. Recent studies demonstrate the
importance of extracellular calcium ion as a modulator of RBF
and GFR during infusion of vasoconstrictor substances [8—12].
These studies document that infusion of calcium entry blockers
results in intrarenal vasodilation and preservation of renal
function during administration of vasoconstrictor stimuli.
The present study was designed to test the hypothesis that
extracellular calcium is important in mediating radiocontrast
medium associated reductions in RBF and GFR. Secondly,
maneuvers which reduce calcium entry into the intracellular
environment or reduce the availability of extracellular calcium
will attenuate the renal hemodynamic response to radiocontrast
medium administration.
Methods. Adult mongrel dogs of either sex, each weighing 15
to 25 kg, were fed an 80 mEq/day sodium, nonwater-restricted
diet for a period of 1 week prior to the study. The animals were
deprived of food and water overnight. The animals were anes-
thetized with intravenous sodium pentobarbital (30 mg/kg),
intubated, and ventilated by a fixed volume positive pressure
respirator on room air. Cannulas were placed in the femoral
artery for blood pressure recording and blood sampling in the
femoral vein for inulin infusion, and in the left ureter for urine
sampling. Inulin (12.5 g/liter) diluted in isotonic saline was
infused into the femoral vein at a rate of I mi/mm and was
continued throughout the experiment. Glomerular filtration rate
was determined by inulin clearance (C1) according to the
formula: (U/P)1 x V, where (U/P)1 is the ratio of urine to
plasma inulin concentration and V is urinary flow rate. A single
kidney and renal artery were exposed and isolated through a
retroperitoneal flank incision; the dogs were placed in dorsal
suspension. An electromagnetic flow probe (Micron Instru-
ments, Inc., Los Angeles, California, USA) was then placed
around the renal artery for determination of RBF. At ap-
proximately 1 hr after completion of the surgery, two 20-gauge
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curved needles with small holes drilled along their sides were
inserted into the renal artery distal to the flow probe, in a
direction opposite the blood flow. Each was maintained patent
by isotonic saline infusions at a rate of 1 mllmin. Once RBF had
stabilized and baseline clearance data were obtained, an injec-
tion of 2 ml in 10 sec of radiocontrast solution, diatrizoate
meglumine and diatrizoate sodium (Renograffin; E. R. Squibb &
Sons, Inc., New Brunswick, New Jersey, USA) into the renal
artery through one of the two needles was performed; the
subsequent changes in renal blood flow were recorded on a strip
recorder. In addition, clearance data were obtained during this
period. All clearance periods were 15 mm in duration. The data
are expressed as mean inulin clearance. The injection of con-
trast medium was repeated in triplicate at 10-mm intervals
(allowing for return of blood flow to the baseline).
After the final bolus infusion of radiocontrast medium was
injected, a recovery (postcontrast) period of 30 mm was utilized
to measure changes in clearance. Following this period,
verapamil (50 tg/min), diltiazem (40 gJmin), or EGTA (10
prnoles/min), was infused through the second renal artery
needle. Verapamil was obtained from G. D. Searle Laborato-
ries, Chicago, Illinois, USA, and diltiazem from Marion Labo-
ratories, Kansas City, Missouri, USA. Ethyleneglycol-bis-(f3-
aminoethylether)-N,N'-tetracetic acid (EGTA) was obtained
from Sigma Chemical Company, St. Louis, Missouri, USA.
After an equilibration period of 30 mm, an inulin clearance was
obtained and the radiocontrast injections, blood flow record-
ings, and clearance periods were repeated in the manner
described above. The left kidney was removed and weighed at
the termination of each experiment. A significant variation
among the dog kidney weights was noted. Thus, we expressed
our RBF and GFR data per gram of kidney weight to correct for
this variance.
Statistics. Results are reported as a mean SE. Comparisons
between control and either verapamil, diltiazem, or EGTA
groups were made through the use of the paired Student's t test.
Renal blood flows are reported as the mean maximum changes
in both vasodilation and vasoconstriction. The data are ex-
pressed as to correct for variations in baseline.
Results. The effects of various drugs on mean arterial pres-
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Abbreviations: RBF, renal blood flow; MAP, mean arterial pressure.
a All results are expressed as means SE.




Control 1.02 0.06 0.55 0.05"
Verapamil 0.83 0.05 0.76 0.04
Diltiazem group
Control 1.03 0.03 0.61 0.07"
Diltiazem 0.86 0.08 0.76 0.11
EGTA group
Control 1.03 0.03 0.55 006b
EGTA 0.84 0.05 0.73 0.06
radiocontrast medium injection. In addition, the duration of
initial vasodilation associated with radiocontrast medium ad-
ministration increased in all treatment groups (40 2 control
vs. 84 5 sec verapamil, P < 0.005; 33 2 control vs. 85
6 sec diltiazem, P < 0.005; and 34 2 control vs. 86 4 sec
EGTA, P < 0.005).
Glomerular filtration. The data are summarized in Table 2
and Figure 2. The radiocontrast medium injection reduced the
mean GFR by 42% (P < 0.05) during the control periods. This
decrement in inulin clearance was attenuated by infusion of
verapamil, diltiazem, or EGTA (—0.47 0.08 control vs.
—0.07 0.02 imIIminIg kidney verapamil, P <0.005; —0.42
0.07 control vs. —0.10 0.04 mlJmi&g kidney diltiazem, P
<0.05, and —0.48 0.06 control vs. —0.11 0.02 im11min/g
kidney EGTA, P < 0.02). Repeated injections of radiocontrast
medium yielded reproducible results in all groups. Although a
variance exists in baseline GFRs between control and experi-
mental groups, it is not statistically significant.
Discussion. The importance of increased intracellular cal-
cium has been postulated as a critical stimulus for intrarenal
Vasodilator phase Vasoconstrictor phase Table 2. The effects of radiocontrast medium administration on













Fig. 1. Effects of radiocontrast medium administration on renal blood
flow responses in the presence and absence of verapamil, diltiazem,
and and EGTA. Symbols are: , control; , verapamil (N 6); El,
diltiazem (N 6); •, EGTA (N = 5); *, P < 0.05.
sure (MAP) after intrarenal infusion are summarized in Table 1.
The results among all groups were similar. Neither the decrease
in calcium by EGTA nor the ablation of its entry by the calcium
antagonists verapamil or diltiazem altered MAP. Furthermore,
administration of contrast medium itself did not alter MAP.
Renal hemodynamics. The renal and systemic hemodynamic
effects of intrarenal radiocontrast medium administration in the
presence and absence of verapamil, diltiazem, and EGTA are
summarized in Table 1 and Figure 1. The baseline RBF did not
significantly differ between the control and verapamil,
diltiazem, or EGTA groups. Verapamil, diltiazem, and EGTA
significantly attenuated the magnitude (—0.63 0.12 control
vs. —0.02 0.08 m1Imin/g kidney verapamil; P < 0.001;
—0.44 0.11 control vs. —0.01 0.09 m1Imin/g kidney
diltiazem; P < 0.005; and —0.48 0.16 control vs. —0.01
0.08 mlImin/g kidney EGTA; P < 0.005) and duration (235
2 control vs. 4 2 sec verapamil, P < 0.001; 194 7 control
vs.6 2secdiltiazem;P<0.001;andl6O 7controlvs.5
2 sec EGTA, P < 0.001) of the vasoconstrictor response to
a Each group has five dogs. All results are expressed as means SE.
b Significant values (P < 0.05) are baseline vs. postcontrast.
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Table 1. The renal and systemic hemodynamic effects of intrarenal radiocontrast-medium injection in the presence and absence of verapamil,diltiaze , and EGTAaMAPmm HgBaseline RBFmi/minig kidneyVasodilator phaseVasoconstrictomi/minig kidneyr phasDurationsecRBF/minlg kidnDurationsecVerapa il group (N =Controlerapami6)133 40 32.60 5+ 1.21.128040 85"—0.630. 20.02 08b3542"Diltiazem group (N =ontroliltiazem124 5.43+0 53 0.13 0.76.10286b—0.4410.Ol. 9"94 72EGTA group (N =5)ControlGTA3.0 2+0.430.1255634 86 4"—0.480.16.018b60 7s2"
Abbreviations: RBF, renal blood flow; MAP, mean arterial pressure.lresults are expressed as meansSE.
"Significant values (P < 0.05) are different from control.
GFR, mi/rnin/g kidneyBaselinePostcontrastVerapamil groupContr l1.020.06.550.0 "Verapamil0.83.0.760.04Diltiazem groupContr l1.030.0.610.07"iltiazem0.8. 80.760.11EGTA groupCont l1.030.0.55006bGTA0.84.0.730.06
radiocontrast medium injection. In addition, the duration of
initial vasodilation associated with radiocontrast medium ad-
ministration increased in all treatment groups (402 c ntrol
vs. 84 5 sec verapamil, P < 0.005; 332 control vs. 85
6 sec diltiazem, P < 0.005; and 34 2 control vs. 86 4 secEGTA, P < 0.005).
Glomerular filtration. The data are summarized in Table 2
and Figure 2. The radiocontrast medium injection reduced the
mean GFR by 42% (P < 0.05) during the control periods. This
decrement in inulin clearance was attenuated by infusion of
verapamil, diltiazem, or EGTA (—0.470.08 control vs.
—0. 70.02 imIIminIg kidney verapamil, P <0.005; —0.420.07 control vs. —0.100.04 m Jmi&g kidney diltiazem, P<0.05,a— .480.06 control vs. —0.110.02 im11min/g
kidney EGTA, P < 0.02). Repeated injections of radiocontrast
medium yielded reproducible results in all groups. Although a
variance exists in baseline GFRs between control and experi-
mental groups, it is not statistically significant.
Discussion. The importance of increased intracellular cal-
cium has been postulated as a critical stimulus for intrarenal
Vasodilator phaseVasoconst ictor phaseTable 2. The effects of radiocontrast medium administration on
glomerular filtration rate in the presence and absence of verapamil,diltiazem, and EGTA*1 0860o 42C5-1—23Fig. 1. Effects of radiocontrast medium administration on renal bloodflow responses in the presence and absence of verapamil, diltiazem,and and EGTA. Symbols are: ,c tr ;,v r pa il(N6); E ,diltiaze  (N6); •, EGTA (N =5 ;*, P < 0.05.
sure (MAP) after intrarenal infusion are summarize  i  Table 1.The results among all groups were s m lar. Neithe  the decreasein calcium by EGTA nor the ablation of its entry by the calcium
antagonists verapamil or diltiaz m ltered MAP. Furthermore,administration of contrast medium itself did not alter MAP.Renal hemodynamics. The renal and systemic he odynamic
effects of intrarenal radiocontrast medium administratio  in thpresence and absence of verap mil, diltiazem, and EGTA are
summarized in Table 1 and Figure 1. The baseline RBF d d notsignificantly differ between the control and verapamil,diltiazem, or EGTA groups. Verapamil, diltiazem, and EGTAsignificantly attenuated the magnitude ( 630.12 co trolvs. —0.08 m1Imin/g kidney verapamil; P < 0.0 ;
— .40.11 control vs. —0.010.09 m1Imin/g k dneydiltiazem; P < 0.005; and —0 480.16 control vs. 010.08 mlImin/g kidney EGTA; P < 0.005) and duration (2352 control vs. 4 2 sec verapamil, P < 0.001; 1947 lvs.6 2secdiltiazem;P<0.001;andl6O 7controlvs.52 sec EGTA, P < 0.001) of the vasoconstrictor response to
a E chgroup has five dogs. All results are expressed as meansSE.
b Significant values (P < 0.05) are baseline vs. postcontrast.
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vasoconstriction [13]. Several studies [8, 9] have demonstrated
that maneuvers which decrease calcium entry into the cell
attenuate decrements in RBF and glomerular filtration in re-
sponse to vasoconstrictor stimuli. Intrarenal administration of
radiocontrast medium is well known to cause decrements in
RBF and GFR; these responses may depend on the availability
of the calcium ion [2, 3, 8, 13]. We postulated that alterations in
calcium ion would attenuate the vasoconstrictive response and
blunt the decrement in GFR associated with radiocontrast
medium administration.
Our experiments demonstrate that calcium antagonism with
verapamil or diltiazem or chelation of calcium with EGTA yield
a significant attenuation in the magnitude and duration of
radiocontrast-mediated intrarenal vasoconstriction. Further-
more, these pharmacologic maneuvers accentuate the initial
period of vasodilation associated with radiocontrast medium
administration. These hemodynamic responses were achieved
at intrarenal doses which did not alter systemic arterial pressure
or baseline RBF.
These studies suggest that calcium is important in the
vasoconstrictive phase associated with radiocontrast medium
administration. A salient role for increased intracellular calcium
as the final mediator of RBF reduction is strengthened by its
subsequent attenuation to administration of three different
pharmacologic maneuvers. Our findings that two different cal-
cium antagonists, verapamil and diltiazem, abolish the renal
vasoconstrictor response to radiocontrast medium argues
against a specific drug effect of either verapamil or diltiazem.
Blockade of the radiocontrast medium associated vasocon-
striction with EGTA provides further evidence that increases in
calcium influx into the cytosol is critical. EGTA abolished the
reduction in RBF during radiocontrast medium administration
in a similar fashion to the calcium antagonists. Therefore,
reduction in RBF during radiocontrast medium administration
appears to depend on the availability of calcium.
Decrements in GFR associated with radiocontrast medium
administration were also blunted by calcium antagonism. This
suggests that both the RBF and glomerular filtration reductions
may be mediated by the same mechanism in which calcium ions
serve as the final mediator. However, decrements in GFR
persist following radiocontrast medium administration despite
recovery of RBF to the baseline. This dissociation between
RBF and GFR is similar to the renal response to adenosine
infusion, reported by Tagawa and Vander [14], whereby GFR
remains depressed despite a normal or even increased RBF. We
cannot exclude a possible role for adenosine in the renal
response to radiocontrast medium administration. Indeed,
adenosine has been identified as an important mediator in the
tubuloglomerular feedback response to hypertonic saline [15], a
solution similar to the physical characteristics of hypertonic
radiocontrast medium. It is possible that infusion of hypertonic
radiocontrast medium results in an increase in sodium transport
as has been documented with infusion of hypertonic saline with
subsequent intrarenal generation of adenosine and activation of
calcium-dependent vasoconstriction. Compatible with this hy-
pothesis is the finding that calcium participates in the mediation
of tubuloglomerular feedback responses [16, 17].
Our studies demonstrate that administration of the calcium
antagonists, verapamil or diltiazem, or the calcium chelater,
EGTA, attenuate the renal vasoconstrictor response associated
with radiocontrast medium administration. In addition, de-
creases in extracellular calcium availability blunt decrements in
radiocontrast medium induced decreases in GFR. These studies
support the importance of calcium in radiocontrast-mediated
changes in renal hemodynamics.
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